Skip to main content
MAXCYTE, INC. logo

MAXCYTE, INC. — Investor Relations & Filings

Ticker · MXCT ISIN · US57777K1060 LEI · 54930053YHXULRFCU991 US Professional, scientific and technical activities
Open in API
Filings indexed 767 across all filing types
Latest filing 2023-09-05 Regulatory Filings
Country US United States of America
Listing US MXCT

About MAXCYTE, INC.

https://www.maxcyte.com/

MaxCyte, Inc. is a cell-engineering company that provides enabling platform technologies to advance the discovery, development, and commercialization of cell-based therapeutics. Its core offering is the ExPERT™ platform, which utilizes proprietary Flow Electroporation® technology for efficient, scalable, and non-viral transfection of complex cells. This technology supports a wide range of applications, including cell therapy, gene editing, antibody and protein production, and vaccine development. Additionally, MaxCyte offers SeQure™ genotoxicity assessment services to evaluate the safety of gene-edited products by detecting on- and off-target effects. The company employs a partnership-driven licensing model to support clients from early-stage research through to clinical and commercial manufacturing.

Recent filings

Filing Released Lang Actions
Baird Global Healthcare Conference Participation
Regulatory Filings Classification · 1% confidence The document is a short announcement (under 5,000 characters) issued via RNS (Regulatory News Service) regarding MaxCyte, Inc.'s participation in an upcoming investor conference. It does not contain the actual presentation materials or a transcript, but rather serves as a notification of an event. According to the 'Menu vs Meal' rule, announcements of events or reports are classified as Regulatory Filings (RNS) when they do not fit into more specific categories like 'Investor Presentation' or 'Call Transcript'.
2023-09-05 English
TR-1: Notification of major holdings
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Notification of major holdings' form, which is the standard regulatory filing used in the UK to report when a shareholder's interest in a company crosses a specific threshold. This falls directly under the definition of a 'Major Shareholding Notification'.
2023-09-04 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from MaxCyte, Inc. regarding 'Total Voting Rights'. It details the issuance of new common stock following the exercise of share options and provides the updated total issued share capital to be used by shareholders for notification calculations. This falls under the category of share capital changes and voting rights updates, which is best classified as 'Share Issue/Capital Change' (SHA).
2023-09-04 English
Exercise of options and PDMR dealing
Director's Dealing Classification · 1% confidence The document is a formal notification of share transactions by a Person Discharging Managerial Responsibilities (PDMR), specifically a Non-Executive Director named John Johnston. It details the exercise of stock options and the subsequent sale of those shares, including specific transaction dates, volumes, and prices. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2023-09-01 English
FORM 4 SUBMISSION
Director's Dealing
2023-08-30 English
TR-1
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Notification of major holdings' form, which is the standard regulatory filing used in the UK to report when a shareholder's interest in a company crosses specific voting rights thresholds. This document explicitly details BlackRock, Inc.'s holdings in MaxCyte, Inc. and follows the standard TR-1 template required by the Financial Conduct Authority (FCA). As it is a formal notification of major shareholding, it fits the 'Major Shareholding Notification' category.
2023-08-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.